stockrowPainReform Ltd. (PRFX) vs Redhill Biopharma Ltd. (RDHL)
- PainReform Ltd. PRFX 0.85 +11.84%
- Redhill Biopharma Ltd. RDHL 0.43 0.00%
PainReform Ltd. and Redhill Biopharma Ltd. are both Drug Manufacturers Specialty & Generic companies. Redhill Biopharma Ltd. is the larger, with a market value of $3.8M against $2.3M — 1.6× the size. Redhill Biopharma Ltd. has the higher net margin (25.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 7 metrics below, Redhill Biopharma Ltd. leads on 5 and PainReform Ltd. on 2.
Valuation
| Metric | PRFX | RDHL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 20.55 |
| P/S | n/m | 0.00 | 2.08 |
| P/B | 0.00 | n/m | 1.79 |
| Price to free cash flow | n/m | n/m | 16.29 |
| EV/EBITDA | 0.97 | n/m | 12.22 |
| EV/Sales | n/m | 6.43 | 2.87 |
| Earnings yield | (156,798.70%) | (142,015.51%) | (15.94%) |
| Free cash flow yield | (101,853.01%) | (231,394.02%) | 0.00% |
Profitability
| Metric | PRFX | RDHL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 0.00% | 35.16% | 53.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 25.20% | (2.45%) |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 0.00% | (0.80%) |
| Return on assets | 0.00% | 0.00% | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack